Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLOFITAMAB vs GLUCAGON: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLOFITAMAB vs GLUCAGON: Safety Overview

Metric GLOFITAMAB GLUCAGON
Total FAERS Reports 1,116 1,452
Deaths Reported 315 206
Death Rate 28.2% 14.2%
Hospitalizations 492 410
Average Patient Age 62.5 yrs 54.6 yrs
% Female Patients 53.2% 43.5%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Genentech, Inc. Amphastar Pharmaceuticals, Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Discontinued